The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The optimist inside me says that if the launch of a new and important product is not newsworthy at the end of a quarter then rather like the €13 million contract that wasn't mentioned - there must be bigger fish to be enjoyed (if you eat fish that is which personally I don't)
So great that we can now compete for NHS tender for antibody test and indeed overseas work. And doubled up that the company does not need to RNS that to make us feel better as something far more important is just around the corner.
on this day of not much going on - great that you came to cheer us all up thanks Wayne - you clearly have no intention of keeping your promise to be not so relentlessly, mind numbingly negative. Please go and torture a different board.
In other news with you all the way SS, yearning for the good old days and as we all know 50 odd new headcount is being brought in to maintain the status quo
Hi Wilson good to see you doing okay
ignoring the noise is challenging but I keep coming back to the same thing; increasing staff numbers by 33% is not done to just to maintain revenue levels or to mark time. The linkedin posts from Samantha imply urgency, which suggests the next leg up is in place and needs to be fulfilled now
is it really that hard to be incredibly impressed that the company you are invested in is leading the field and producing innovative products that help better decisions, saving lives and will help keep the economy going
please cheer up wayne, you did promise to try
Wayne can the glass just for once be just a tincey bit full for you for once.
Great day lots of news, coverage, job listings, 6% up, buys showing 3 times sells
There must be another parade you can try and rain on
7 vacancies all NHS related across the country,
does anyone know when these were posted on Novacyt web site?
given this how on earth does the oddo bloke keep his job after last week's valuation
Totally agree
not precise numbers - effectively 150 staff employed last year producing say on average 40 million turnover a month from June onwards.. Presume the extra 30 odd staff since then are not there to mark time. So given a 20% increase in staff numbers we could jump to the conclusion that revenue should be growing by 20% to nearer 50 million a month
seems to have gone green in Paris with a spate of small buys far outweighing the sells.
Totally agree with the Butcher of Novacyt - those who write negative whingey posts are doing their own holding a disservice, the sun is out and Novacyt continues to be on the recruitment drive for excellence :
Daryl Borley our new clinical performance director fresh from AZN, we are recruiting for a clinical trials director in London continued positive flow - try some it makes you feel better